
Novo Nordisk Sues Hims Over Copycat Drugs, Super Bowl Breaks Betting Record
Market update for Monday February 9, 2026
Check out the Public app for incredible investing tools and to support the show (LINK)
Follow us on Instagram (@TheRundownDaily) for bonus content and instant reactions.
In today’s episode:
Stocks rally to end last week, but Wall Street remains skeptical of the bounce
Novo Nordisk sues Hims over alleged copycat weight-loss drugs and GLP-1 patents
China urges banks to limit exposure to U.S. Treasuries, rattling bond markets
Super Bowl betting hits a record as prediction markets take share from sportsbooks
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.